Eli Lilly (LLY) has filed a lawsuit against the heads of the Department of Health and Human Services and one of its agencies, seeking a court ruling that would allow the company’s plan to tighten the way it provides lucrative drug discounts to hospitals, The Wall Street Journal’s Peter Loftus reports. The suit follows one filed on Tuesday by Johnson & Johnson (JNJ) that challenged the Health Resources and Services Administration’s rejection of its plan to overhaul how it provides required drug discounts to certain hospitals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly and Co (NYSE:LLY) Sues Federal Health Agency over Hospital Drug Discounts
- Wolfe sees attractive Eli Lilly opportunity on price drop, starts at Outperform
- Eli Lilly initiated with an Outperform at Wolfe Research
- Eli Lilly call volume above normal and directionally bullish
- Eli Lilly announces results from Phase 3 SURMOUNT-1 three-year study